BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1023840)

  • 1. [A new system of analysis for partial thromboplastin time. Comparison with other blood coagulation tests in liver diseases].
    Pagliano FM; Slucca P; Cestari G
    Arch Sci Med (Torino); 1976; 133(4):321-5. PubMed ID: 1023840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation in liver diseases of a new blood coagulation test for the determination of factors II, VII and X].
    Pagliano FM; Cestari G; Slucca P
    Arch Sci Med (Torino); 1976; 133(4):315-20. PubMed ID: 1023839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepato-quick--a new thromboplastin time system: a comparison with normotest and thrombotest (author's transl)].
    Fischer M; Falkensammer C
    Wien Klin Wochenschr; 1974 Oct; 86(19):577-83. PubMed ID: 4432516
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical use of a test for determination of coagulation factors II, X and VII].
    Cascino A; Cangiano C; Attili AF
    Minerva Med; 1975 Aug; 66(55):2743-9. PubMed ID: 1161171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of thromboplastin time with a new standardized thromboplastin from human placenta: results of a cooperative study].
    Barthels M; Bruhn HD; Duckert F; Meyer JG; Dati F; Fuhge P
    J Clin Chem Clin Biochem; 1987 Apr; 25(4):267-80. PubMed ID: 3625130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine tests as measures of the total intrinsic blood clotting potential. A comparison of whole blood clotting time (WBCT), recalcification time of citrated plasma (RTST), partial thromboplastin time (PTT), and activated partial thromboplastin time (APTT).
    Korsan-Bengtsen K
    Scand J Haematol; 1971; 8(5):359-68. PubMed ID: 4109186
    [No Abstract]   [Full Text] [Related]  

  • 7. [The diagnostic value of the aminophenazone breath test in chronic liver diseases].
    Sensing H; Treutler J; Haustein KO; Hüller G
    Z Gesamte Inn Med; 1991 Sep; 46(13):478-82. PubMed ID: 1962492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser.
    Hjorth B; Kjaersgaard E
    Scand J Clin Lab Invest; 1977 Feb; 37(1):15-20. PubMed ID: 616022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated partial thromboplastin time performed on capillary blood.
    Boumerfeg M; Aurousseau MH; Le Roux G; Lortholary P
    Nouv Rev Fr Hematol (1978); 1989; 31(5):359-61. PubMed ID: 2587206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily modifications of plasma fibrinogen platelets aggregation, Howell's time, PTT, TT, and antithrombin II in normal subjects and in patients with vascular disease.
    Petralito A; Mangiafico RA; Gibiino S; Cuffari MA; Miano MF; Fiore CE
    Chronobiologia; 1982; 9(2):195-201. PubMed ID: 7117042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New methods of coagulation analysis using chromogenic substrates].
    Witt I
    J Clin Chem Clin Biochem; 1977 Apr; 15(4):239-44. PubMed ID: 864387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of lupus-like anticoagulants by an enzyme-linked immunosorbent assay using a partial thromboplastin as antigen; a comparative study.
    Arnout J; Huybrechts E; Vanrusselt M; Falcon C; Vermylen J
    Thromb Haemost; 1990 Aug; 64(1):26-31. PubMed ID: 2125756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of neutrophil apoptosis on haemostatic activation in chronic liver disease patients.
    Essawy FM; Bekheet IW; Saleh AF; Madkour ME; Bayoumi Eel-D
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):535-42. PubMed ID: 18685437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemostatic changes in the course of different chronic hepatopathies].
    Ruggiero G; De Biasi R; Lembo N; Giusti G
    Minerva Med; 1975 Feb; 66(13):595-601. PubMed ID: 1113909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercoagulability associated with chronic ulcerative colitis: changes in blood coagulation factors.
    Lee LC; Spittell JA; Sauer WG; Owen CA; Thompson JH
    Gastroenterology; 1968 Jan; 54(1):76-85. PubMed ID: 5638294
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1).
    Exner T; Triplett DA; Taberner DA; Howard MA; Harris EN
    Thromb Haemost; 1990 Nov; 64(3):478-84. PubMed ID: 2128977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factor analysis in patients on long-term anticoagulation.
    Perkins HA; Biben RL
    Calif Med; 1970 Mar; 112(3):1-7. PubMed ID: 5451608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of clotting tests in liver disease.
    Thachil J
    Postgrad Med J; 2008 Apr; 84(990):177-81. PubMed ID: 18424573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic abnormalities in chronic aggressive hepatitis and liver cirrhosis.
    Ruggiero G; De Biasi R; Attanasio S; Bile G; Giusti G
    Acta Hepatogastroenterol (Stuttg); 1975 Aug; 22(4):221-8. PubMed ID: 1179944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of prothrombin time and activated partial thromboplastin time in dogs with hepatic disease.
    Badylak SF; Van Vleet JF
    Am J Vet Res; 1981 Dec; 42(12):2053-6. PubMed ID: 7340574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.